Abstract
The effects of angiotensin II and angiotensin III were compared at prejunctional and postjunctional AT1 receptors of the rabbit thoracic aorta. Furthermore, the influence of PD123319, losartan and eprosartan on these effects was also compared. To study prejunctional effects, the tissues were preincubated with (3H)-noradrenaline, superfused and electrically stimulated (1 Hz, 2 ms, 50 mA, 5 min). To study postjunctional effects, non-cumulative concentration–response curves were determined. Both angiotensin II and angiotensin III were more potent prejunctionally than postjunctionally. In the case of angiotensin II, the EC50 was 12 times lower at the prejunctional than at the postjunctional level, while that of angiotensin III was 30 times lower prejunctionally. Furthermore, whereas angiotensin II was about 33 times more potent than angiotensin III postjunctionally, it was only 12 times more potent than angiotensin III prejunctionally. Eprosartan did not differentiate between prejunctional and postjunctional effects of both angiotensins. In contrast, PD123319 and losartan did differentiate; however, whereas PD123319 concentration-dependently antagonised the facilitation of tritium release caused by angiotensin II and angiotensin III and had no influence on the contraction of the aortic rings elicited by the peptides, losartan did the opposite: it concentration-dependently antagonised the contractions caused by the peptides on the aortic rings and exerted no influence on the facilitatory effect of angiotensin II and angiotensin III. These results show that prejunctional and postjunctional receptors for angiotensin II and angiotensin III are different and underline the hypothesis that postjunctional AT1 receptors belong to the AT1A subtype, while prejunctional AT1 receptors belong to the AT1B subtype.
Similar content being viewed by others
References
Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153:586–600
Albino-Teixeira A, Matias A, Polónia J, Azevedo I (1991) Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J Hypertens 9 [Suppl 6]:S196–S197
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58
Balt JC, Mathy MJ, Pfaffendorf M, Van Zwieten PA (2001a) Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. J Hypertens 19:2241–2250
Balt JC, Mathy MJ, Nap A, Pfaffendorf M, Van Zwieten PA (2001b) Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol 38:141–148
Balt JC, Mathy MJ, Nap A, Pfaffendorf M, Van Zwieten PA (2002) Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery. J Cardiovasc Pharmacol 40:50–57
Chiba S, Yang X-P (2003) The preferential inhibitory effect of olmesartan, a new angiotensin II type 1 antagonist, on sympathetic nerve terminals in isolated canine splenic artery. J Pharmacol Sci 92:381–386
Cox SL, Ben A, Story DF, Ziogas J (1995) Evidence for the involvement of different receptor subtypes in pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Br J Pharmacol 114:1057–1063
Cox SL, Trendelenburg AU, Starke K (1999) Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br J Pharmacol 127:1256–1262
De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger TH (2000) International union of pharmacology. XXIII. The angiotensin receptors. Pharmacol Rev 52:415–472
Dendorfer A, Raasch W, Tempel K, Dominiak P (2002) Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat. J Hypertens 20:1151–1156
Dulin NO, Ernsberger P, Suciu DJ, Douglas JG (1994) Rabbit renal epithelial angiotensin II receptors. Am J Physiol 267:F776–F782
El Muayed M, Stegbauer J, Oberhauser V, Vonend O, Rump LC (2004) AT1 and AT2-receptor antagonists inhibit Ang II-mediated facilitation of noradrenaline release in human atria. J Cardiovasc Pharmacol 43:318–324
Ernsberger P, Zhou J, Damon TH, Douglas JG (1992) Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Am J Physiol 263:F411–F416
Fabiani ME, Sourial M, Thomas WG, Johnston CI, Frauman AG (2001) Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia. J Endocrinol 171:97–108
Guimarães S, Moura D (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53:319–356
Guimarães S, Osswald W (1969) Adrenergic receptors in the veins of the dogs. Eur J Pharmacol 5:133–140
Guimarães S, Brandão F, Paiva MQ (1978) A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitter. Naunyn-Schmiedebergs Arch Pharmacol 305:185–188
Guimarães S, Paiva MQ, Moura D (1998) Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries. Br J Pharmacol 124:1207–1212
Guimarães S, Pinheiro H, Tavares P, Loio A, Moura D (2001) Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors. Naunyn-Schmiedebergs Arch Pharmacol 363:509–514
Guimarães S, Morato M, Sousa T, Albino-Teixeira A (2003) Hypertension due to blockade of adenosine receptors. Pharmacol Toxicol 92:160–162
Helmer UM (1964) Action of natural angiotensin II and synthetic analogues on strips of rabbit aorta. Am J Physiol 207:368–370
Kenakin T (1997) Diffusion and drug concentration in receptor compartments. In: Kenakin K (ed) Pharmacologic analysis of drug-receptor interaction. Lippincott-Raven, Philadelphia, pp 145–197
Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG Jr (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597–598
Ma X, Abboud FM, Chapleau MW (2001) A novel effect of angiotensin on renal sympathetic nerve activity in mice. J Hypertens 19:609–618
Mota A, Guimarães S (2003) Influence of α2-autoreceptor stimulation on the facilitation by angiotensin II and bradykinin of noradrenaline release. Naunyn-Schmiedebergs Arch Pharmacol 368:443–447
Nap A, Balt JC, Mathy M-J, Pfaffendorf M, Van Zwieten PA (2004) Different AT1 receptor subtypes at pre- and postjunctional sites: AT1A versus AT1B receptors. J Cardiovasc Pharmacol 43:14–20
Ohlstein EH, Brooks DP, Feuerstein GZ, Ruffolo RR (1997) Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade. Pharmacology 55:244–254
Pinheiro H, Moura D, Albino-Teixeira A, Alves C, Torres L, Guimarães S (2002) A comparison of AT1 angiotensin II antagonists at pre- and postjunctional angiotensin II receptors of the rat tail artery. Naunyn-Schmiedebergs Arch Pharmacol 366:537–542
Shetty SS, Delgrande D (2000) Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan and losartan. J Pharmacol Exp Ther 294:179–186
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124
Susuki Y, Matsumura Y, Egi Y, Morimoto S (1992) Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis by stimulation of renal nerves in anaesthetized dogs. J Pharmacol Exp Ther 263:956–963
Trendelenburg U (1966) Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 18:629–640
Wong PC, Price WA Jr, Chiu AT, Duncia JW, Carini DJ, Wexler RR, Johnson AJ, Timmermans PBMWM (1990) Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3714: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 255:211–217
Worck RH, Ibsen H, Frandsen E, Dige-Petersen H (1997) AT1 receptor blockade and sympathoadrenal response to insulin-induced hypoglycemia in humans. Am J Physiol 272:E414–E421
Zhou J, Ernsberger P, Douglas JG (1993) A novel angiotensin receptor subtype in rat mesangium coupling to adenylyl cyclase. Hypertension 21:1035–1038
Acknowledgements
This work was supported by Project POCTI/FCB/40832/2001. The experiments complied with Portuguese current law.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guimarães, S., Carneiro, C., Brandão, F. et al. A pharmacological differentiation between postjunctional (AT1A) and prejunctional (AT1B) angiotensin II receptors in the rabbit aorta. Naunyn-Schmiedeberg's Arch Pharmacol 370, 262–269 (2004). https://doi.org/10.1007/s00210-004-0977-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-004-0977-7